nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Thiotepa—sarcoma	0.178	0.458	CbGbCtD
Salbutamol—CYP3A4—Mitoxantrone—sarcoma	0.0765	0.197	CbGbCtD
Salbutamol—CYP3A4—Vincristine—sarcoma	0.0527	0.136	CbGbCtD
Salbutamol—CYP3A4—Etoposide—sarcoma	0.0483	0.124	CbGbCtD
Salbutamol—CYP3A4—Doxorubicin—sarcoma	0.0329	0.0848	CbGbCtD
Salbutamol—Influenza—Epirubicin—sarcoma	0.000865	0.00141	CcSEcCtD
Salbutamol—Pruritus—Thiotepa—sarcoma	0.000865	0.00141	CcSEcCtD
Salbutamol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000863	0.00141	CcSEcCtD
Salbutamol—Tachycardia—Etoposide—sarcoma	0.000857	0.0014	CcSEcCtD
Salbutamol—Body temperature increased—Vincristine—sarcoma	0.000857	0.0014	CcSEcCtD
Salbutamol—Abdominal pain—Vincristine—sarcoma	0.000857	0.0014	CcSEcCtD
Salbutamol—Skin disorder—Etoposide—sarcoma	0.000853	0.00139	CcSEcCtD
Salbutamol—Hyperhidrosis—Etoposide—sarcoma	0.000849	0.00139	CcSEcCtD
Salbutamol—Abdominal pain upper—Doxorubicin—sarcoma	0.000846	0.00138	CcSEcCtD
Salbutamol—Hypokalaemia—Doxorubicin—sarcoma	0.000843	0.00138	CcSEcCtD
Salbutamol—Angina pectoris—Epirubicin—sarcoma	0.000843	0.00138	CcSEcCtD
Salbutamol—Urticaria—Mitoxantrone—sarcoma	0.000838	0.00137	CcSEcCtD
Salbutamol—Anorexia—Etoposide—sarcoma	0.000837	0.00137	CcSEcCtD
Salbutamol—Diarrhoea—Thiotepa—sarcoma	0.000836	0.00137	CcSEcCtD
Salbutamol—Abdominal pain—Mitoxantrone—sarcoma	0.000834	0.00136	CcSEcCtD
Salbutamol—Body temperature increased—Mitoxantrone—sarcoma	0.000834	0.00136	CcSEcCtD
Salbutamol—Bronchitis—Epirubicin—sarcoma	0.000832	0.00136	CcSEcCtD
Salbutamol—Diarrhoea—Dactinomycin—sarcoma	0.00083	0.00136	CcSEcCtD
Salbutamol—Nasopharyngitis—Doxorubicin—sarcoma	0.000828	0.00135	CcSEcCtD
Salbutamol—Hypotension—Etoposide—sarcoma	0.00082	0.00134	CcSEcCtD
Salbutamol—Dysuria—Epirubicin—sarcoma	0.000809	0.00132	CcSEcCtD
Salbutamol—Dizziness—Thiotepa—sarcoma	0.000808	0.00132	CcSEcCtD
Salbutamol—Abdominal distension—Doxorubicin—sarcoma	0.000806	0.00132	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Epirubicin—sarcoma	0.000804	0.00131	CcSEcCtD
Salbutamol—Influenza—Doxorubicin—sarcoma	0.000801	0.00131	CcSEcCtD
Salbutamol—Asthma—Doxorubicin—sarcoma	0.000801	0.00131	CcSEcCtD
Salbutamol—Hypersensitivity—Vincristine—sarcoma	0.000798	0.00131	CcSEcCtD
Salbutamol—Paraesthesia—Etoposide—sarcoma	0.000788	0.00129	CcSEcCtD
Salbutamol—Dyspnoea—Etoposide—sarcoma	0.000783	0.00128	CcSEcCtD
Salbutamol—Hyperglycaemia—Epirubicin—sarcoma	0.000781	0.00128	CcSEcCtD
Salbutamol—Somnolence—Etoposide—sarcoma	0.00078	0.00128	CcSEcCtD
Salbutamol—Angina pectoris—Doxorubicin—sarcoma	0.00078	0.00128	CcSEcCtD
Salbutamol—Hypersensitivity—Mitoxantrone—sarcoma	0.000778	0.00127	CcSEcCtD
Salbutamol—Asthenia—Vincristine—sarcoma	0.000778	0.00127	CcSEcCtD
Salbutamol—Vomiting—Thiotepa—sarcoma	0.000777	0.00127	CcSEcCtD
Salbutamol—Drowsiness—Epirubicin—sarcoma	0.000772	0.00126	CcSEcCtD
Salbutamol—Vomiting—Dactinomycin—sarcoma	0.000771	0.00126	CcSEcCtD
Salbutamol—Rash—Thiotepa—sarcoma	0.000771	0.00126	CcSEcCtD
Salbutamol—Bronchitis—Doxorubicin—sarcoma	0.00077	0.00126	CcSEcCtD
Salbutamol—Dermatitis—Thiotepa—sarcoma	0.00077	0.00126	CcSEcCtD
Salbutamol—Headache—Thiotepa—sarcoma	0.000766	0.00125	CcSEcCtD
Salbutamol—Rash—Dactinomycin—sarcoma	0.000765	0.00125	CcSEcCtD
Salbutamol—Decreased appetite—Etoposide—sarcoma	0.000763	0.00125	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Etoposide—sarcoma	0.000758	0.00124	CcSEcCtD
Salbutamol—Asthenia—Mitoxantrone—sarcoma	0.000757	0.00124	CcSEcCtD
Salbutamol—Fatigue—Etoposide—sarcoma	0.000757	0.00124	CcSEcCtD
Salbutamol—Neuropathy peripheral—Epirubicin—sarcoma	0.000756	0.00124	CcSEcCtD
Salbutamol—Stomatitis—Epirubicin—sarcoma	0.000752	0.00123	CcSEcCtD
Salbutamol—Jaundice—Epirubicin—sarcoma	0.000752	0.00123	CcSEcCtD
Salbutamol—Constipation—Etoposide—sarcoma	0.000751	0.00123	CcSEcCtD
Salbutamol—Pain—Etoposide—sarcoma	0.000751	0.00123	CcSEcCtD
Salbutamol—Conjunctivitis—Epirubicin—sarcoma	0.00075	0.00123	CcSEcCtD
Salbutamol—Urinary tract infection—Epirubicin—sarcoma	0.00075	0.00123	CcSEcCtD
Salbutamol—Dysuria—Doxorubicin—sarcoma	0.000749	0.00122	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000744	0.00122	CcSEcCtD
Salbutamol—Diarrhoea—Vincristine—sarcoma	0.000742	0.00121	CcSEcCtD
Salbutamol—Sweating—Epirubicin—sarcoma	0.00074	0.00121	CcSEcCtD
Salbutamol—Haematuria—Epirubicin—sarcoma	0.000736	0.0012	CcSEcCtD
Salbutamol—Epistaxis—Epirubicin—sarcoma	0.000728	0.00119	CcSEcCtD
Salbutamol—Nausea—Thiotepa—sarcoma	0.000726	0.00119	CcSEcCtD
Salbutamol—Sinusitis—Epirubicin—sarcoma	0.000724	0.00118	CcSEcCtD
Salbutamol—Feeling abnormal—Etoposide—sarcoma	0.000723	0.00118	CcSEcCtD
Salbutamol—Hyperglycaemia—Doxorubicin—sarcoma	0.000722	0.00118	CcSEcCtD
Salbutamol—Diarrhoea—Mitoxantrone—sarcoma	0.000722	0.00118	CcSEcCtD
Salbutamol—Nausea—Dactinomycin—sarcoma	0.00072	0.00118	CcSEcCtD
Salbutamol—Gastrointestinal pain—Etoposide—sarcoma	0.000718	0.00117	CcSEcCtD
Salbutamol—Dizziness—Vincristine—sarcoma	0.000717	0.00117	CcSEcCtD
Salbutamol—Drowsiness—Doxorubicin—sarcoma	0.000714	0.00117	CcSEcCtD
Salbutamol—Neuropathy peripheral—Doxorubicin—sarcoma	0.0007	0.00114	CcSEcCtD
Salbutamol—Urticaria—Etoposide—sarcoma	0.000697	0.00114	CcSEcCtD
Salbutamol—Haemoglobin—Epirubicin—sarcoma	0.000696	0.00114	CcSEcCtD
Salbutamol—Stomatitis—Doxorubicin—sarcoma	0.000696	0.00114	CcSEcCtD
Salbutamol—Jaundice—Doxorubicin—sarcoma	0.000696	0.00114	CcSEcCtD
Salbutamol—Rhinitis—Epirubicin—sarcoma	0.000694	0.00114	CcSEcCtD
Salbutamol—Abdominal pain—Etoposide—sarcoma	0.000694	0.00113	CcSEcCtD
Salbutamol—Body temperature increased—Etoposide—sarcoma	0.000694	0.00113	CcSEcCtD
Salbutamol—Urinary tract infection—Doxorubicin—sarcoma	0.000694	0.00113	CcSEcCtD
Salbutamol—Conjunctivitis—Doxorubicin—sarcoma	0.000694	0.00113	CcSEcCtD
Salbutamol—Haemorrhage—Epirubicin—sarcoma	0.000693	0.00113	CcSEcCtD
Salbutamol—Hypoaesthesia—Epirubicin—sarcoma	0.000689	0.00113	CcSEcCtD
Salbutamol—Vomiting—Vincristine—sarcoma	0.000689	0.00113	CcSEcCtD
Salbutamol—Pharyngitis—Epirubicin—sarcoma	0.000687	0.00112	CcSEcCtD
Salbutamol—Sweating—Doxorubicin—sarcoma	0.000684	0.00112	CcSEcCtD
Salbutamol—Urinary tract disorder—Epirubicin—sarcoma	0.000684	0.00112	CcSEcCtD
Salbutamol—Rash—Vincristine—sarcoma	0.000683	0.00112	CcSEcCtD
Salbutamol—Dermatitis—Vincristine—sarcoma	0.000683	0.00112	CcSEcCtD
Salbutamol—Haematuria—Doxorubicin—sarcoma	0.000681	0.00111	CcSEcCtD
Salbutamol—Connective tissue disorder—Epirubicin—sarcoma	0.000681	0.00111	CcSEcCtD
Salbutamol—Urethral disorder—Epirubicin—sarcoma	0.000679	0.00111	CcSEcCtD
Salbutamol—Headache—Vincristine—sarcoma	0.000679	0.00111	CcSEcCtD
Salbutamol—Epistaxis—Doxorubicin—sarcoma	0.000673	0.0011	CcSEcCtD
Salbutamol—Vomiting—Mitoxantrone—sarcoma	0.000671	0.0011	CcSEcCtD
Salbutamol—Sinusitis—Doxorubicin—sarcoma	0.00067	0.00109	CcSEcCtD
Salbutamol—Rash—Mitoxantrone—sarcoma	0.000665	0.00109	CcSEcCtD
Salbutamol—Dermatitis—Mitoxantrone—sarcoma	0.000665	0.00109	CcSEcCtD
Salbutamol—Headache—Mitoxantrone—sarcoma	0.000661	0.00108	CcSEcCtD
Salbutamol—Hypersensitivity—Etoposide—sarcoma	0.000647	0.00106	CcSEcCtD
Salbutamol—Tinnitus—Epirubicin—sarcoma	0.000646	0.00106	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—sarcoma	0.000644	0.00105	CcSEcCtD
Salbutamol—Nausea—Vincristine—sarcoma	0.000644	0.00105	CcSEcCtD
Salbutamol—Flushing—Epirubicin—sarcoma	0.000643	0.00105	CcSEcCtD
Salbutamol—Cardiac disorder—Epirubicin—sarcoma	0.000643	0.00105	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—sarcoma	0.000643	0.00105	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—sarcoma	0.000641	0.00105	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—sarcoma	0.000638	0.00104	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—sarcoma	0.000636	0.00104	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—sarcoma	0.000633	0.00103	CcSEcCtD
Salbutamol—Asthenia—Etoposide—sarcoma	0.00063	0.00103	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—sarcoma	0.00063	0.00103	CcSEcCtD
Salbutamol—Angiopathy—Epirubicin—sarcoma	0.000628	0.00103	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—sarcoma	0.000628	0.00103	CcSEcCtD
Salbutamol—Nausea—Mitoxantrone—sarcoma	0.000627	0.00102	CcSEcCtD
Salbutamol—Immune system disorder—Epirubicin—sarcoma	0.000626	0.00102	CcSEcCtD
Salbutamol—Mediastinal disorder—Epirubicin—sarcoma	0.000624	0.00102	CcSEcCtD
Salbutamol—Chills—Epirubicin—sarcoma	0.000622	0.00102	CcSEcCtD
Salbutamol—Pruritus—Etoposide—sarcoma	0.000621	0.00102	CcSEcCtD
Salbutamol—Arrhythmia—Epirubicin—sarcoma	0.000619	0.00101	CcSEcCtD
Salbutamol—Mental disorder—Epirubicin—sarcoma	0.000607	0.000992	CcSEcCtD
Salbutamol—Malnutrition—Epirubicin—sarcoma	0.000603	0.000986	CcSEcCtD
Salbutamol—Diarrhoea—Etoposide—sarcoma	0.000601	0.000982	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—sarcoma	0.000598	0.000977	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—sarcoma	0.000595	0.000972	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—sarcoma	0.000595	0.000972	CcSEcCtD
Salbutamol—Flatulence—Epirubicin—sarcoma	0.000594	0.000971	CcSEcCtD
Salbutamol—Tension—Epirubicin—sarcoma	0.000592	0.000967	CcSEcCtD
Salbutamol—Dysgeusia—Epirubicin—sarcoma	0.00059	0.000965	CcSEcCtD
Salbutamol—Nervousness—Epirubicin—sarcoma	0.000586	0.000957	CcSEcCtD
Salbutamol—Back pain—Epirubicin—sarcoma	0.000583	0.000953	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—sarcoma	0.000581	0.000951	CcSEcCtD
Salbutamol—Dizziness—Etoposide—sarcoma	0.000581	0.000949	CcSEcCtD
Salbutamol—Muscle spasms—Epirubicin—sarcoma	0.00058	0.000948	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—sarcoma	0.000579	0.000946	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—sarcoma	0.000578	0.000944	CcSEcCtD
Salbutamol—Chills—Doxorubicin—sarcoma	0.000575	0.00094	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—sarcoma	0.000573	0.000936	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—sarcoma	0.000561	0.000918	CcSEcCtD
Salbutamol—Ill-defined disorder—Epirubicin—sarcoma	0.000559	0.000915	CcSEcCtD
Salbutamol—Vomiting—Etoposide—sarcoma	0.000558	0.000912	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—sarcoma	0.000558	0.000912	CcSEcCtD
Salbutamol—Agitation—Epirubicin—sarcoma	0.000554	0.000906	CcSEcCtD
Salbutamol—Rash—Etoposide—sarcoma	0.000554	0.000905	CcSEcCtD
Salbutamol—Dermatitis—Etoposide—sarcoma	0.000553	0.000904	CcSEcCtD
Salbutamol—Headache—Etoposide—sarcoma	0.00055	0.000899	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—sarcoma	0.00055	0.000899	CcSEcCtD
Salbutamol—Tension—Doxorubicin—sarcoma	0.000547	0.000895	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—sarcoma	0.000546	0.000893	CcSEcCtD
Salbutamol—Malaise—Epirubicin—sarcoma	0.000544	0.000889	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—sarcoma	0.000542	0.000886	CcSEcCtD
Salbutamol—Vertigo—Epirubicin—sarcoma	0.000542	0.000886	CcSEcCtD
Salbutamol—Syncope—Epirubicin—sarcoma	0.000541	0.000884	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—sarcoma	0.00054	0.000882	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—sarcoma	0.000536	0.000877	CcSEcCtD
Salbutamol—Palpitations—Epirubicin—sarcoma	0.000533	0.000871	CcSEcCtD
Salbutamol—Loss of consciousness—Epirubicin—sarcoma	0.00053	0.000866	CcSEcCtD
Salbutamol—Cough—Epirubicin—sarcoma	0.000526	0.00086	CcSEcCtD
Salbutamol—Nausea—Etoposide—sarcoma	0.000521	0.000852	CcSEcCtD
Salbutamol—Hypertension—Epirubicin—sarcoma	0.000521	0.000851	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—sarcoma	0.000518	0.000846	CcSEcCtD
Salbutamol—Arthralgia—Epirubicin—sarcoma	0.000513	0.000839	CcSEcCtD
Salbutamol—Chest pain—Epirubicin—sarcoma	0.000513	0.000839	CcSEcCtD
Salbutamol—Myalgia—Epirubicin—sarcoma	0.000513	0.000839	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—sarcoma	0.000513	0.000838	CcSEcCtD
Salbutamol—Anxiety—Epirubicin—sarcoma	0.000512	0.000836	CcSEcCtD
Salbutamol—Discomfort—Epirubicin—sarcoma	0.000507	0.000829	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—sarcoma	0.000503	0.000822	CcSEcCtD
Salbutamol—Dry mouth—Epirubicin—sarcoma	0.000502	0.000821	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—sarcoma	0.000501	0.000819	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—sarcoma	0.0005	0.000818	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—sarcoma	0.000493	0.000806	CcSEcCtD
Salbutamol—Oedema—Epirubicin—sarcoma	0.000492	0.000804	CcSEcCtD
Salbutamol—Anaphylactic shock—Epirubicin—sarcoma	0.000492	0.000804	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—sarcoma	0.00049	0.000802	CcSEcCtD
Salbutamol—Infection—Epirubicin—sarcoma	0.000489	0.000799	CcSEcCtD
Salbutamol—Cough—Doxorubicin—sarcoma	0.000487	0.000796	CcSEcCtD
Salbutamol—Shock—Epirubicin—sarcoma	0.000484	0.000791	CcSEcCtD
Salbutamol—Nervous system disorder—Epirubicin—sarcoma	0.000483	0.000789	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—sarcoma	0.000482	0.000787	CcSEcCtD
Salbutamol—Tachycardia—Epirubicin—sarcoma	0.00048	0.000785	CcSEcCtD
Salbutamol—Skin disorder—Epirubicin—sarcoma	0.000478	0.000781	CcSEcCtD
Salbutamol—Hyperhidrosis—Epirubicin—sarcoma	0.000476	0.000778	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—sarcoma	0.000475	0.000776	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—sarcoma	0.000475	0.000776	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—sarcoma	0.000475	0.000776	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—sarcoma	0.000473	0.000774	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—sarcoma	0.000469	0.000767	CcSEcCtD
Salbutamol—Anorexia—Epirubicin—sarcoma	0.000469	0.000767	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—sarcoma	0.000465	0.000759	CcSEcCtD
Salbutamol—Hypotension—Epirubicin—sarcoma	0.00046	0.000752	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—sarcoma	0.000455	0.000744	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—sarcoma	0.000455	0.000744	CcSEcCtD
Salbutamol—Infection—Doxorubicin—sarcoma	0.000452	0.000739	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000448	0.000733	CcSEcCtD
Salbutamol—Shock—Doxorubicin—sarcoma	0.000448	0.000732	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—sarcoma	0.000447	0.00073	CcSEcCtD
Salbutamol—Insomnia—Epirubicin—sarcoma	0.000445	0.000728	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—sarcoma	0.000444	0.000726	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—sarcoma	0.000442	0.000723	CcSEcCtD
Salbutamol—Paraesthesia—Epirubicin—sarcoma	0.000442	0.000722	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—sarcoma	0.00044	0.00072	CcSEcCtD
Salbutamol—Dyspnoea—Epirubicin—sarcoma	0.000439	0.000717	CcSEcCtD
Salbutamol—Somnolence—Epirubicin—sarcoma	0.000437	0.000715	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—sarcoma	0.000434	0.00071	CcSEcCtD
Salbutamol—Dyspepsia—Epirubicin—sarcoma	0.000433	0.000708	CcSEcCtD
Salbutamol—Decreased appetite—Epirubicin—sarcoma	0.000428	0.000699	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—sarcoma	0.000425	0.000696	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000425	0.000695	CcSEcCtD
Salbutamol—Fatigue—Epirubicin—sarcoma	0.000424	0.000694	CcSEcCtD
Salbutamol—Constipation—Epirubicin—sarcoma	0.000421	0.000688	CcSEcCtD
Salbutamol—Pain—Epirubicin—sarcoma	0.000421	0.000688	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000415	0.000678	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—sarcoma	0.000412	0.000673	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—sarcoma	0.000409	0.000668	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—sarcoma	0.000406	0.000664	CcSEcCtD
Salbutamol—Feeling abnormal—Epirubicin—sarcoma	0.000406	0.000663	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—sarcoma	0.000405	0.000662	CcSEcCtD
Salbutamol—Gastrointestinal pain—Epirubicin—sarcoma	0.000402	0.000658	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—sarcoma	0.000401	0.000655	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—sarcoma	0.000396	0.000647	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000393	0.000643	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—sarcoma	0.000393	0.000642	CcSEcCtD
Salbutamol—Urticaria—Epirubicin—sarcoma	0.000391	0.000639	CcSEcCtD
Salbutamol—Pain—Doxorubicin—sarcoma	0.000389	0.000637	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—sarcoma	0.000389	0.000637	CcSEcCtD
Salbutamol—Abdominal pain—Epirubicin—sarcoma	0.000389	0.000636	CcSEcCtD
Salbutamol—Body temperature increased—Epirubicin—sarcoma	0.000389	0.000636	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—sarcoma	0.000375	0.000613	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000372	0.000609	CcSEcCtD
Salbutamol—Hypersensitivity—Epirubicin—sarcoma	0.000363	0.000593	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—sarcoma	0.000362	0.000591	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—sarcoma	0.00036	0.000588	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—sarcoma	0.00036	0.000588	CcSEcCtD
Salbutamol—Asthenia—Epirubicin—sarcoma	0.000353	0.000577	CcSEcCtD
Salbutamol—Pruritus—Epirubicin—sarcoma	0.000348	0.000569	CcSEcCtD
Salbutamol—Diarrhoea—Epirubicin—sarcoma	0.000337	0.00055	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—sarcoma	0.000335	0.000548	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—sarcoma	0.000327	0.000534	CcSEcCtD
Salbutamol—Dizziness—Epirubicin—sarcoma	0.000325	0.000532	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—sarcoma	0.000322	0.000527	CcSEcCtD
Salbutamol—Vomiting—Epirubicin—sarcoma	0.000313	0.000511	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—sarcoma	0.000312	0.000509	CcSEcCtD
Salbutamol—Rash—Epirubicin—sarcoma	0.00031	0.000507	CcSEcCtD
Salbutamol—Dermatitis—Epirubicin—sarcoma	0.00031	0.000507	CcSEcCtD
Salbutamol—Headache—Epirubicin—sarcoma	0.000308	0.000504	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—sarcoma	0.000301	0.000492	CcSEcCtD
Salbutamol—Nausea—Epirubicin—sarcoma	0.000292	0.000478	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—sarcoma	0.00029	0.000473	CcSEcCtD
Salbutamol—Rash—Doxorubicin—sarcoma	0.000287	0.000469	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—sarcoma	0.000287	0.000469	CcSEcCtD
Salbutamol—Headache—Doxorubicin—sarcoma	0.000285	0.000466	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—sarcoma	0.00027	0.000442	CcSEcCtD
